| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |